Dermapharm Holding SE (ETR:DMP)
Germany · Delayed Price · Currency is EUR 42.95
+1.20 (2.87%)
Jul 29, 2026, 3:39 PM CET
Dermapharm Holding SE Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,168 | 1,165 | 1,181 | 1,135 | 1,025 | 942.91 |
Revenue Growth | -1.36% | -1.34% | 4.00% | 10.79% | 8.68% | 18.78% |
Gross Profit Gross Profit Growth | 795.75 | 781 | 746.67 | 700.43 | 651.28 | 609.32 |
Operating Income Operating Income Growth | 231.55 | 220.67 | 216.93 | 182.89 | 243.69 | 298.47 |
Net Income Net Income Growth | 144.21 | 132.41 | 113.79 | 62.37 | 134.24 | 209.58 |
Earnings Per Share EPS Growth | 2.68 | 2.46 | 2.11 | 1.16 | 2.49 | 3.89 |
EPS Growth | 39.58% | 16.59% | 81.90% | -53.41% | -35.99% | 144.65% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Branded Pharmaceuticals Branded Pharmaceuticals Growth | 648 | 629.16 | 589.43 | 537.44 | 629.69 | - |
Other Healthcare Products Other Healthcare Products Growth | 361.7 | 363.84 | 369.96 | 402.33 | 180.67 | - |
Reconciliation/Group Holding Company Reconciliation/Group Holding Company Growth | -32.07 | -31.45 | -27.77 | -39.91 | -30.52 | -1.48 |
Parallel Import Business Parallel Import Business Growth | 190.76 | 203.44 | 249.15 | 235.49 | 244.94 | 230.63 |
Total Total Growth | 1,168 | 1,165 | 1,181 | 1,135 | 1,025 | 942.91 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 225.93 | 203.41 | 121.31 | 158.72 | 151.02 | 161.41 |
Total Debt Total Debt Growth | 1,039 | 1,052 | 979.61 | 1,080 | 516.45 | 580.3 |
Net Cash (Debt) Net Cash Growth | -813.54 | -848.88 | -858.3 | -921.66 | -365.43 | -418.89 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -15.12 | -15.77 | -15.94 | -17.12 | -6.79 | -7.78 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 284.74 | 229.15 | 201.38 | 219.42 | 288.53 | 250.37 |
Capital Expenditures CapEx Growth | -43.89 | -42.12 | -38.24 | -41.54 | -39.01 | -61.2 |
Free Cash Flow Free Cash Flow Growth | 240.85 | 187.03 | 163.14 | 177.88 | 249.52 | 189.17 |
Free Cash Flow Growth | 83.50% | 14.64% | -8.29% | -28.71% | 31.91% | 109.48% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 68.11% | 67.04% | 63.24% | 61.69% | 63.55% | 64.62% |
Operating Margin | 19.82% | 18.94% | 18.37% | 16.11% | 23.78% | 31.65% |
Pretax Margin | 16.72% | 15.75% | 14.57% | 9.34% | 21.11% | 31.07% |
Profit Margin | 12.26% | 11.28% | 9.46% | 5.33% | 12.94% | 22.16% |
FCF Margin | 20.61% | 16.05% | 13.82% | 15.67% | 24.35% | 20.06% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.880 | 0.880 | 0.900 | 0.880 | 1.050 | 2.170 |
Dividend Per Share Growth | -2.22% | -2.22% | 2.27% | -16.19% | -51.61% | 146.59% |
Dividend Yield | 2.11% | 2.29% | 2.26% | 2.48% | 5.78% | 0.99% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.58 | 16.00 | 18.44 | 36.50 | 15.07 | 22.96 |
Forward PE | 15.36 | 15.94 | 16.66 | 17.44 | 10.61 | 22.27 |
P/FCF Ratio | 8.59 | 11.33 | 12.84 | 12.82 | 8.10 | 25.42 |
PS Ratio | 1.75 | 1.82 | 1.77 | 2.01 | 1.97 | 5.10 |